Cancer

CMC Biologics to manufacture Zymeworks antibody

CMC Biologics to manufacture Zymeworks antibody

By Zachary Brennan

Contract manufacturer CMC Biologics and Zymeworks have entered into a master services agreement whereby CMC will perform the process development, formulation development and cGMP clinical manufacturing of a recombinant human IgG1 bi-specific (heterodimeric)...

Dendreon's European Provenge CMO to add capacity with plant acqusition

Provenge CMO PharmaCell contracted for 2nd product

By Gareth Macdonald

PharmaCell, the CMO that makes Provenge for Dendreon in Europe, has agreed to buy a facility from TiGenix to add capacity and a manufacturing contract for a second commercial product.

New Melanoma Vaccine Tech Enters Ph I Trial

Harvard’s New Melanoma Vaccine Tech Enters Ph I Trial

By Zachary Brennan

A newly developed implantable melanoma vaccine is now in Phase I clinical trials thanks to the efforts of a cross-disciplinary team of engineers, scientists and clinicians from Harvard University and the Dana-Farber Cancer Institute.

CST Unveils HER3 Rabbit mAb for Researchers

CST Unveils HER3 Rabbit mAb for Researchers

By Zachary Brennan

Cell Signaling Technology launched a new HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors. 

CST to Offer HER3 mAb for Researchers

CST to Offer HER3 mAb for Researchers

Cell Signaling Technology announced this week it has introduced a HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors.